However, if SIBO stems from chronic neurological disorders or EDS it may require longer-term management through prokinetics, dietary adjustments, and periodic intervention cycles to keep symptoms under control
Orlistat has traditionally been a first-line option due to its established safety profile and availability, though its modest efficacy (typically 3-5% additional weight loss beyond lifestyle intervention) and gastrointestinal side effects limit its appeal
Asking these questions will empower you to collaborate with your provider on a treatment plan that feels right for you, balancing efficacy, convenience, and cost
Long-term risks are rare but include potential for thyroid cancer (based on animal studies), pancreatitis, gallbladder disease, and kidney problems
The truth is Type 2 diabetes medications are not a sign of failure